Alcohol-Preferring Mice Have Different Brain Opioid Peptide Levels That Change With Drinking
Alcohol-preferring C57BL/6J mice had lower baseline nociceptin and dynorphin in reward regions, and alcohol consumption further altered opioid peptide levels, linking the opioid/nociceptin systems to alcohol preference.
Quick Facts
What This Study Found
Alcohol-preferring mice had lower baseline nociceptin and dynorphin B in reward regions, with alcohol consumption producing additional changes in met-enkephalin levels, linking opioid/nociceptin system configuration to alcohol preference.
Key Numbers
How They Did This
Animal study comparing basal opioid peptide levels (nociceptin, dynorphin B, met-enkephalin) in alcohol-preferring C57BL/6J mice vs alcohol-avoiding DBA/2J mice, and measuring changes after voluntary alcohol consumption.
Why This Research Matters
Identifying pre-existing opioid system differences in alcohol-preferring animals suggests genetic opioid vulnerability to alcoholism, which could enable identification and early intervention in at-risk humans.
The Bigger Picture
Alcoholism risk may be partly determined by baseline brain opioid peptide levels. People born with less nociceptin (an anti-reward signal) in their reward circuits may be biologically predisposed to seeking alcohol's rewarding effects.
What This Study Doesn't Tell Us
Mouse strain comparison; results may not directly translate to human genetics. Voluntary drinking model may not fully represent human alcoholism. Multiple brain regions measured increase type I error risk.
Questions This Raises
- ?Can opioid peptide levels predict alcoholism risk in humans?
- ?Could boosting nociceptin reduce alcohol preference?
- ?Does the low baseline nociceptin create a reward deficit that drives alcohol seeking?
Trust & Context
- Key Stat:
- Born different Alcohol-preferring mice had lower baseline nociceptin and dynorphin before ever tasting alcohol — a pre-existing opioid vulnerability to addiction
- Evidence Grade:
- Preliminary animal evidence using strain comparison to identify opioid peptide correlates of alcohol preference.
- Study Age:
- Published in 2000. The nociceptin system's role in alcohol addiction has been further explored, with NOP receptor modulators investigated as potential alcoholism treatments.
- Original Title:
- Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice.
- Published In:
- Brain research bulletin, 53(2), 219-26 (2000)
- Authors:
- Ploj, K(2), Roman, E, Gustavsson, L, Nylander, I
- Database ID:
- RPEP-00613
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Are some people biologically predisposed to alcoholism?
This study suggests yes — in mice at least. Animals that prefer alcohol were born with lower levels of anti-reward peptides in their brain, creating a biological tilt toward seeking alcohol's rewarding effects.
Could this lead to alcoholism prevention?
If similar opioid peptide differences exist in humans, they could serve as biomarkers for alcoholism risk. People identified as at-risk could receive early intervention or preventive treatment targeting the opioid system.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00613APA
Ploj, K; Roman, E; Gustavsson, L; Nylander, I. (2000). Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice.. Brain research bulletin, 53(2), 219-26.
MLA
Ploj, K, et al. "Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice.." Brain research bulletin, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Basal levels and alcohol-induced changes in nociceptin/orpha..." RPEP-00613. Retrieved from https://rethinkpeptides.com/research/ploj-2000-basal-levels-and-alcoholinduced
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.